Response to comment on Cefalu et Al. The alarming and rising costs of diabetes and prediabetes: a call for action! Diabetes care 2014;37:3137-3138.

Cefalu WT, Petersen MP, Ratner RE

Longitudinal Correlates of Health Risk Behaviors in Children and Adolescents with Type 2 Diabetes.

Ievers-Landis CE, Walders-Abramson N, Amodei N, Drews KL, Kaplan J, Levitt Katz LE, Lavietes S, Saletsky R, Seidman D, Yasuda P, Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study Group

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC, Diabetes Prevention Program Research Group

The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.

Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC, Ratner RE, Diabetes Prevention Program Research Group

Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial.

Levitt Katz L, Gidding SS, Bacha F, Hirst K, McKay S, Pyle L, Lima JA, TODAY Study Group

A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.

Werner-Lin A, Ratner R, Hoskins LM, Lieber C

Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.

Vinik A, Rosenstock J, Sharma U, Feins K, Hsu C, Merante D, DS5565-A-U201 US Phase II Study Investigators

Association of modifiable risk factors and left ventricular ejection fraction among hospitalized Native Hawaiians and Pacific Islanders with heart failure.

Mau MK, Seto TB, Kaholokula JK, Howard B, Ratner RE

The alarming and rising costs of diabetes and prediabetes: a call for action!

Cefalu WT, Petersen MP, Ratner RE

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME

We can change the natural history of type 2 diabetes.

Phillips LS, Ratner RE, Buse JB, Kahn SE

Communicating science-based recommendations with memorable and actionable guidelines.

Ratner RK, Riis J

Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetes.

Walders-Abramson N, Venditti EM, Ievers-Landis CE, Anderson B, El Ghormli L, Geffner M, Kaplan J, Koontz MB, Saletsky R, Payan M, Yasuda P, Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study Group

Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF, Diabetes Prevention Program Research Group